These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11526391)

  • 1. Tolerogenic strategies to halt or prevent type 1 diabetes.
    Cooke A; Phillips JM; Parish NM
    Nat Immunol; 2001 Sep; 2(9):810-5. PubMed ID: 11526391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological reversal of autoimmune diabetes without hematopoietic replacement of beta cells.
    Suri A; Calderon B; Esparza TJ; Frederick K; Bittner P; Unanue ER
    Science; 2006 Mar; 311(5768):1778-80. PubMed ID: 16556846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. beta-Cell death during progression to diabetes.
    Mathis D; Vence L; Benoist C
    Nature; 2001 Dec; 414(6865):792-8. PubMed ID: 11742411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene- and cell-based therapeutics for type I diabetes mellitus.
    Bottino R; Lemarchand P; Trucco M; Giannoukakis N
    Gene Ther; 2003 May; 10(10):875-89. PubMed ID: 12732873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic mixed chimerism derived from allogeneic embryonic stem cells prevents autoimmune diabetes mellitus in NOD mice.
    Verda L; Kim DA; Ikehara S; Statkute L; Bronesky D; Petrenko Y; Oyama Y; He X; Link C; Vahanian NN; Burt RK
    Stem Cells; 2008 Feb; 26(2):381-6. PubMed ID: 17975228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New type of human blood stem cell: a double-edged sword for the treatment of type 1 diabetes.
    Zhao Y; Lin B; Dingeldein M; Guo C; Hwang D; Holterman MJ
    Transl Res; 2010 May; 155(5):211-6. PubMed ID: 20403575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Islet recovery and reversal of murine type 1 diabetes in the absence of any infused spleen cell contribution.
    Nishio J; Gaglia JL; Turvey SE; Campbell C; Benoist C; Mathis D
    Science; 2006 Mar; 311(5768):1775-8. PubMed ID: 16556845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does autoantigen administration inhibit recurrence of type 1 diabetes in transplanted islets?
    Mojtahedi Z; Farjadian S; Ghaderi A
    Med Hypotheses; 2005; 64(5):986-8. PubMed ID: 15780496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of low avidity T cells in the protection against type 1 diabetes: a modeling investigation.
    Khadra A; Santamaria P; Edelstein-Keshet L
    J Theor Biol; 2009 Jan; 256(1):126-41. PubMed ID: 18950644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Islet replacement vs. regeneration: hope or hype?
    Ramiya V; Schatz D
    Pediatr Diabetes; 2004; 5 Suppl 2():45-56. PubMed ID: 15601374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with chronic pancreatitis have islet progenitor cells in their ducts, but reversal of overt diabetes in NOD mice by anti-CD3 shows no evidence for islet regeneration.
    Phillips JM; O'Reilly L; Bland C; Foulis AK; Cooke A
    Diabetes; 2007 Mar; 56(3):634-40. PubMed ID: 17327430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Of mice and men: use of animal models to identify possible interventions for the prevention of autoimmune type 1 diabetes in humans.
    Serreze DV; Chen YG
    Trends Immunol; 2005 Nov; 26(11):603-7. PubMed ID: 16140038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice.
    Ansari MJ; Fiorina P; Dada S; Guleria I; Ueno T; Yuan X; Trikudanathan S; Smith RN; Freeman G; Sayegh MH
    Clin Immunol; 2008 Feb; 126(2):140-7. PubMed ID: 17889619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-CD20 treatment prolongs syngeneic islet graft survival and delays the onset of recurrent autoimmune diabetes.
    Hu C; Deng S; Wong FS; Wen L
    Ann N Y Acad Sci; 2008 Dec; 1150():217-9. PubMed ID: 19120299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell receptor-transgenic NOD mice: a reductionist approach to understand autoimmune diabetes.
    Yang Y; Santamaria P
    J Autoimmun; 2004 Mar; 22(2):121-9. PubMed ID: 14987740
    [No Abstract]   [Full Text] [Related]  

  • 16. Autoreactive T cells in endocrine/organ-specific autoimmunity: why has progress been so slow?
    Roep BO
    Springer Semin Immunopathol; 2002 Dec; 24(3):261-71. PubMed ID: 12503054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintaining or breaking CD8+ T-cell tolerance to beta islet cell antigens: lessons from transgenic mouse models.
    Piaggio E; Hartemann-Heurtier A; Cabarrocas J; Desbois S; Mars LT; Zappulla JP; Liblau RS
    J Autoimmun; 2004 Mar; 22(2):115-20. PubMed ID: 14987739
    [No Abstract]   [Full Text] [Related]  

  • 18. Indefinite islet protection from autoimmune destruction in nonobese diabetic mice by agarose microencapsulation without immunosuppression.
    Kobayashi T; Aomatsu Y; Iwata H; Kin T; Kanehiro H; Hisanaga M; Ko S; Nagao M; Nakajima Y
    Transplantation; 2003 Mar; 75(5):619-25. PubMed ID: 12640299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNF-alpha impairs peripheral tolerance towards beta-cells, and local costimulation by B7.1 enhances the effector function of diabetogenic T cells.
    Skak K; Guerder S; Picarella DE; Brenden N; Flavell RA; Michelsen BK
    Eur J Immunol; 2003 May; 33(5):1341-50. PubMed ID: 12731060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short administration of polyclonal anti-T cell antibody (ALS) in NOD mice with extensive insulitis prevents subsequent development of autoimmune diabetes.
    Ogawa N; Minamimura K; Kodaka T; Maki T
    J Autoimmun; 2006 Jun; 26(4):225-31. PubMed ID: 16713179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.